10-Q: Lifeway Foods Reports 3.3% Net Sales Increase in Q1 2025, Driven by Kefir Demand

Lifeway Foods announces a 3.3% increase in net sales for Q1 2025, marking the 22nd consecutive quarter of year-over-year growth, fueled by strong demand for its kefir products.

Summary

• Lifeway Foods reported a 3.3% increase in net sales for the first quarter of 2025, reaching $46.1 million.
• This marks the 22nd consecutive quarter of year-over-year net sales growth for the company.
• The increase was primarily driven by higher volumes of branded drinkable kefir.
• Adjusting for strategic exits and distributor changes, net sales increased approximately 11%.
• Net income for the quarter was $3.5 million, or $0.23 per basic and diluted common share, compared to $2.4 million in the same period last year.
• The company reaffirmed its target to deliver Adjusted EBITDA of $45 $50 million in FY2027.
• Gross profit as a percentage of net sales was 24.0%, compared to 25.8% in the prior year.
• The company had $25 million available for future borrowings under its Revolving Credit Facility as of March 31, 2025.

Sentiment

Score: 7

Explanation: The report is generally positive, highlighting revenue growth and increased profitability. However, there are some concerns about gross profit margin and increased expenses, leading to a moderately positive sentiment.

Positives

• The company achieved its 22nd consecutive quarter of year-over-year net sales growth.
• Net income increased to $3.5 million, or $0.23 per share, up from $2.4 million in the prior year.
• Lifeway has received commitments at key retailers for more than 2,000 total incremental points of distribution across its product lines.
• The company surpassed $5 million in gross sales in the last full week of April, a record week for the business.
• Lifeway products are now available in 40 airports across the country.

Negatives

• Gross profit as a percentage of net sales decreased to 24.0% from 25.8% in the prior year, driven by unfavorable milk pricing and increased trade promotions.
• Selling expenses as a percentage of net sales increased to 10.2% from 8.3% due to continued investments in marketing activities.
• Net cash used in operating activities was $150,000 compared to net cash provided by operating activities of $1.546 million in the same period in 2024.

Risks

• Changes in the pricing of commodities could impact profitability.
• Actions and decisions of competitors and customers, including price competition, could affect sales.
• Disruptions to the supply chain, manufacturing, or distribution capabilities, including cybersecurity threats, could impact operations.
• Adverse economic conditions in the United States could reduce consumer spending.
• Uncertainty regarding proposals or other actions taken by shareholders related to the unsolicited proposal made by Danone North America PBC (Danone) to acquire all of the shares of Lifeway stock that Danone does not already own.

Future Outlook

The company expects the accelerating consumer focus on health and wellness to drive increased demand for its products and plans to continue investments behind its core branded products in 2025 to capitalize on the market opportunity.

Management Comments

• Julie Smolyansky, President and Chief Executive Officer of Lifeway Foods, commented, 'Were thrilled to begin 2025 with continued topline momentum, delivering our 22nd consecutive quarter of year-over-year net sales growth.'
• Ms. Smolyansky added that the company delivered nearly 11% volume-led growth in the quarter on a like-for-like basis, underscoring the power of the Lifeway branded products and the loyalty of the growing customer base.

Industry Context

The report highlights the increasing consumer focus on health and wellness, which is driving demand for probiotic and protein-rich foods like Lifeway's kefir and farmer cheese. The company is also targeting consumers using GLP-1 medications and those looking for foods that naturally stimulate GLP-1 hormone production.

Comparison to Industry Standards

• It is difficult to compare Lifeway directly to industry standards without more specific information on comparable companies.
• However, the company's focus on probiotic and health-focused products aligns with broader trends in the food and beverage industry.
• Companies like Danone (though they made an offer to acquire Lifeway), Chobani, and other yogurt and dairy producers could be considered peers, but their product portfolios and market positions may differ significantly.

Stakeholder Impact

• Shareholders will likely view the revenue growth and increased profitability positively.
• Employees may benefit from the company's continued growth and investments.
• Customers will continue to have access to Lifeway's probiotic products.
• Suppliers may see increased demand for raw materials as Lifeway expands its production.

Next Steps

• The company plans to continue its investments behind its core branded products in 2025.
• Lifeway aims to further capitalize on the market opportunity and extend upon the momentum it has achieved.

Key Dates

Keywords

kefir, net sales, probiotic, Lifeway Foods, financial results, EBITDA, Q1 2025